Receive Windhover's unique market insight fast with our free alert
service 'Windhover's Update', including the latest abstracts
and summaries from:
• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight
Sign up
now
|
|
|
2010-2011
Networking Opportunities and Continuing Education
|
|
Pharmaceutical Strategic Alliances
September 21-23, 2010 - New York, NY
More information...
- Add to MS Outlook |
 |
|
|
2010 Phoenix Conference
October 14-17, 2010 - Scottsdale, AZ
More information... |
 |
|
|
PharmAsia Summit
October 25-26, 2010 - San Francisco, CA
More Information... |
 |
|
|
IN3 Summit
October 27-29, 2010 - San Francisco, CA
More information...
- Add to MS Outlook |
 |
 |
|
|
Therapeutic Area Partnerships
November 2-4, 2010 - Boston, MA
More Information... |
|
 |
|
|
Bohemian Medical Device Summit
December 1-3, 2010 - Florence, Italy
More Information... |
 |
|
|
FDA/CMS Summit
December 9-10, 2010 - Washington, DC
More Information...
- Add to MS Outlook |
 |
|
|
IN3 West
February 22-24, 2011 - Las Vegas, NV
More information... |
|
 |
|
|
BIOWindhover/
Pharma Strategic Outlook
March 30-April 1, 2011 - New York, NY
More information... |
|
 |
|
|
rEvolution 2011
To Be Announced - Miami, FL
More information... |
 |
|
|
IN3 Europe
To Be Announced - Paris, France
More information... |
|
 |
|
|
Wharton/Windhover Program
Pharma Program For Executives
To Be Announced - Philadelphia, PA
More information... |
 |
|
|
IN3 East
June 21-23, 2011 - Boston, MA
More information... |
|
 |
|
|
Euro-Biotech Forum
To Be Announced - Paris, France
More information... |
|
 |
|
|
|
|
 |
|
 |
|
|
| |
 |
Novartis Follows Its Own Business Development Model into Molecular Diagnostics
Novartis is mirroring its approach to pharma R&D and leveraging the byproducts of its biomarker work there to build a commercial molecular diagnostics franchise. The head of the unit talks about its structure, strategy and programs. . . [MORE] (IN VIVO)
Bioactive Technologies For Bone Replacement
Expanded indications for bone morphogenetic proteins and new alternatives to those first-generation bone growth factors have the potential to grow the $2 billion market for bone replacement materials. . . [MORE] (Start-Up)
Laser Cataract Surgery Comes into Focus at ASCRS
The mood was primarily upbeat at April's annual meeting of the American Society of Cataract and Refractive Surgery. Most in attendance expected a modest rebound in procedure volumes for 2010. . . [MORE] (Medtech Insight)
FDA, Drug Development and Health Care Reform: A Panel Discussion
Current and former FDA officials and a former Big Pharma head of R&D discuss FDA and the relationship between a regulator and the industry it regulates when it comes to drug development. . . [MORE] (The RPM Report)
Read
more from the latest:
IN VIVO,
Start-Up,
The RPM Report,
Medtech Insight, "The Pink Sheet",
"The Pink Sheet" DAILY,
"The Rose Sheet",
"The Tan Sheet",
PharmAsia News,
Pharmaceutical Approvals Monthly, and
"The Gray Sheet".
|
|
|
|
| |
|
|
|
|
|
